Phibro Animal Health Files 8-K on Financials

TL;DR

PHIBRO files 8-K with financial updates, check for Q4 results.

AI Summary

Phibro Animal Health Corporation filed an 8-K on May 8, 2024, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details the company's financial performance and provides updated information relevant to investors.

Why It Matters

This filing provides investors with crucial updates on Phibro Animal Health's financial performance and operational status, enabling informed investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

• Phibro Animal Health Corporation (company) — Registrant
• May 8, 2024 (date) — Filing Date
• Delaware (jurisdiction) — State of Incorporation
• Teaneck, New Jersey (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share PAHC NASDAQ Sto

Filing Documents

• pahc-20240508x8k.htm (8-K) — 31KB
• pahc-20240508xex99d1.htm (EX-99.1) — 812KB
• pahc-20240508xex99d1001.jpg (GRAPHIC) — 9KB
• 0001558370-24-007371.txt ( ) — 1006KB
• pahc-20240508.xsd (EX-101.SCH) — 3KB
• pahc-20240508_lab.xml (EX-101.LAB) — 16KB
• pahc-20240508_pre.xml (EX-101.PRE) — 10KB
• pahc-20240508x8k_htm.xml (XML) — 5KB

02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On May 8, 2024, Phibro Animal Health Corporation issued a press release announcing its operating results for the fiscal quarter ended March 31, 2024 and updated financial guidance for the fiscal year ending June 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this report, including the exhibit attached hereto, is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of, or otherwise regarded as filed under, the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01 FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated May 8, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. PHIBRO ANIMAL HEALTH CORPORATION Registrant Date: May 8, 2024 By: /s/ Judith Weinstein Name: Judith Weinstein Title: Senior Vice President, General Counsel and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR